CAC2 Childhood Cancer Community News Digest (October 20-26)

Assorted News from the Last Week:

South African authorities have suspended eight pupils linked to a case of alleged bullying of a childhood cancer patient who recently completed treatment that has caused national outrage.

Skivolo, the red panda character with neuroblastoma helps young patients cope in this effort from Neon and CAC2 Supporting Organization Member United Therapeutics.

Redefining the Future of Cancer – Reflections from the International Cancer Week” by CAC2 Student Member Joshua Omale.

Patient-specific sequencing panels enable sensitive circulating tumor DNA analysis in rhabdomyosarcoma independent of genetic profile.

Drug that stops tumors’ blood supply could help kids with bone cancer live longer.

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing.

Cancer drug quality in Africa is a worry, four-country study finds.

Genome-wide association study of childhood B-cell acute lymphoblastic leukemia reveals novel African ancestry-specific susceptibility loci.

Clinical characteristics and short-term outcomes of pediatric lymphoma: a retrospective cohort study from a large tertiary hospital in a low- and middle-income country.

Upcoming Webinars, Online Opportunities, and Meetings:

The Science of Childhood Cancer is an interactive, weekly lecture series designed to engage the scientific community on key questions in pediatric cancer research. The Fall 2025 lecture season will run August 14 through November 20. Click here for more information and to register.

Action Days 2026 will be held in Washington, D.C. from February 24-25, 2026. Registration is open! Action Days registration will close on Friday, January 30, or when we reach 225 participants. Click here for more information and to register.

Past Recordings:

Julie Chessell, RN (nurse, parent, and passionate advocate with the Hepatoblastoma Resource Network) presented a podcast about life after hepatoblastoma, sharing updates on her son Brock’s journey after his liver transplant and the realities of survivorship beyond treatment.

Take Action

United Therapeutics is launching the Braving Neuroblastoma Ambassador Program. It’s designed for patients and caregivers who want to share their neuroblastoma experience in ways that feel authentic and impactful—whether that’s speaking at events, helping shape educational resources, or simply offering support to others who are just beginning their journey.

If youd like to share your experience to help others on their journey, email Connect@BravingNB.com.


SUBSCRIBE

Sign up to receive a copy of CAC2’s free childhood cancer news digest in your inbox each week.

This field is for validation purposes and should be left unchanged.
Name(Required)
Email(Required)

Picture of Vickie Buenger

Vickie Buenger

Leave a Reply

Sign up for our Newsletter

We protect your privacy and won’t share your information.